Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer

NCT00442260 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: DOXIL
DRUG: Abraxane

Sponsor

West Virginia University

Collaborators

[object Object]